Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Mahlknecht

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Parkinsonism & Related Disorders|February 4, 2010
The clinical progression of Parkinson's diseaseWerner Poewe, Philipp Mahlknecht
Neurologic Clinics|April 14, 2020
Pharmacologic Treatment of Motor Symptoms Associated with Parkinson DiseaseWerner Poewe, Philipp Mahlknecht
Expert Review of Neurotherapeutics|September 26, 2012
Combined assessment of midbrain hyperechogenicity, hyposmia and motor asymmetry improves diagnostic accuracy in early Parkinson's diseaseWerner Poewe, Philipp Mahlknecht
Journal of Parkinson'S Disease|March 1, 2024
Pharmacotherapy for Disease Modification in Early Parkinson's Disease: How Early Should We Be?Philipp Mahlknecht, Werner Poewe
Journal of Neural Transmission (Vienna, Austria : 1996)|May 30, 2013
Is there a need to redefine Parkinson's disease?Philipp Mahlknecht, Werner Poewe
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 2015
Therapeutic advances in multiple system atrophy and progressive supranuclear palsyWerner Poewe, Philipp Mahlknecht, Florian Krismer
Journal of Parkinson'S Disease|October 21, 2015
The Concept of Prodromal Parkinson's DiseasePhilipp Mahlknecht, Klaus Seppi, Werner Poewe
Drugs|May 20, 2026
Recent Developments in the Drug Treatment of Parkinson's DiseaseSimon Leiter, Philipp Mahlknecht, Werner Poewe
Journal of Neurology|June 4, 2015
Deep brain stimulation for movement disorders: update on recent discoveries and outlook on future developmentsPhilipp Mahlknecht, Patricia Limousin, Thomas Foltynie
Current Opinion in Neurology|July 10, 2012
Emerging therapies for Parkinson's diseaseWerner Poewe, Philipp Mahlknecht, Joseph Jankovic
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Parkinsonism & Related Disorders|February 4, 2010
The clinical progression of Parkinson's diseaseWerner Poewe, Philipp Mahlknecht
Neurologic Clinics|April 14, 2020
Pharmacologic Treatment of Motor Symptoms Associated with Parkinson DiseaseWerner Poewe, Philipp Mahlknecht
Expert Review of Neurotherapeutics|September 26, 2012
Combined assessment of midbrain hyperechogenicity, hyposmia and motor asymmetry improves diagnostic accuracy in early Parkinson's diseaseWerner Poewe, Philipp Mahlknecht
Journal of Parkinson'S Disease|March 1, 2024
Pharmacotherapy for Disease Modification in Early Parkinson's Disease: How Early Should We Be?Philipp Mahlknecht, Werner Poewe
Journal of Neural Transmission (Vienna, Austria : 1996)|May 30, 2013
Is there a need to redefine Parkinson's disease?Philipp Mahlknecht, Werner Poewe
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 2015
Therapeutic advances in multiple system atrophy and progressive supranuclear palsyWerner Poewe, Philipp Mahlknecht, Florian Krismer
Journal of Parkinson'S Disease|October 21, 2015
The Concept of Prodromal Parkinson's DiseasePhilipp Mahlknecht, Klaus Seppi, Werner Poewe
Drugs|May 20, 2026
Recent Developments in the Drug Treatment of Parkinson's DiseaseSimon Leiter, Philipp Mahlknecht, Werner Poewe
Journal of Neurology|June 4, 2015
Deep brain stimulation for movement disorders: update on recent discoveries and outlook on future developmentsPhilipp Mahlknecht, Patricia Limousin, Thomas Foltynie
Current Opinion in Neurology|July 10, 2012
Emerging therapies for Parkinson's diseaseWerner Poewe, Philipp Mahlknecht, Joseph Jankovic
Pageof 9